Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar;29(3):305-314.
doi: 10.1007/s10552-018-1006-3. Epub 2018 Feb 9.

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Nancy Krieger  1 , Sheida Nabavi  2 , Pamela D Waterman  3 , Ninah S Achacoso  4 , Luana Acton  4 , Stuart J Schnitt  5 , Laurel A Habel  4
Affiliations

Feasibility of analyzing DNA copy number variation in breast cancer tumor specimens from 1950 to 2010: how old is too old?

Nancy Krieger et al. Cancer Causes Control. 2018 Mar.

Abstract

Purpose: The purpose of the study was to assess the feasibility of quantifying long-term trends in breast tumor DNA copy number variation (CNV) profiles.

Methods: We evaluated CNV profiles in formalin-fixed paraffin-embedded (FFPE) tumor specimens from 30 randomly selected Kaiser Permanente Northern California health plan women members diagnosed with breast cancer from 1950 to 2010. Assays were conducted for five cases per decade who had available tumor blocks and pathology reports.

Results: As compared to the tumors from the 1970s to 2000s, the older tumors dating back to the 1950s and 1960s were much more likely to (1) fail quality control, and (2) have fewer CNV events (average 23 and 31 vs. 58 to 69), fewer CNV genes (average 5.1 and 3.7k vs. 8.1 to 10.3k), shorter CNV length (average 2,440 and 3,300k vs. 5,740 to 9,280k), fewer high frequency Del genes (37 and 25% vs. 54 to 76%), and fewer high frequency high_Amp genes (20% vs. 56 to 73%). On average, assay interpretation took an extra 60 min/specimen for cases from the 1960s versus 20 min/specimen for the most recent tumors.

Conclusions: Assays conducted in the mid-2010s for CNVs may be feasible for FFPE tumor specimens dating back to the 1980s, but less feasible for older specimens.

Keywords: Archival specimen; Biomarker; Breast cancer; DNA copy number variation; Epidemiology; Historical trend.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Zhang F, Gu W, Hurles ME, Lupski JR. Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet. 2009 doi: 10.1146/annurev.genom.9.081307.164217. - DOI - PMC - PubMed
    1. Tang Y-C, Amon A. Gene copy-number alterations: a cost-benefit analysis. Cell. 2013;152:394–405. - PMC - PubMed
    1. Hart L, O’Driscoll M. Causes and consequences of structural genomic alterations in the human genome. eLS. 2013 doi: 10.1002/9780470015902.a0024976. - DOI
    1. Thompson PA, Brewster AM, Kim-Anh D, Baladandayuthapani V, Broom BM, Edgerton ME, Hahn KM, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy ML. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLoS One. 2011;6:e23543. - PMC - PubMed
    1. Brewster AM, Thompson P, Sahin AA, Do K, Edgerton M, Murray JL, Tsavachidis S, Zhou R, Liu Y, Zhang L, Mills G, Bondy M. Copy number imbalances between screen- and symptom-detected breast cancers and impact on disease-free survival. Cancer Prev Res (Phila) 2011;4:1609e1616. - PMC - PubMed

Publication types